KMT2D and hepatocellular carcinoma: Several genes have been implicated to play a role in the chromatin modification including ARID, BAP1, Histone-lysine N-methyltransferase 2D (KMT2D), and cAMP response element-binding protein (CREBBP) with 50% of HCC patients found to have an alteration in one of these pathways.